IRIS
SORRENTINO, SABATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.810
AS - Asia 1.495
EU - Europa 637
SA - Sud America 216
AF - Africa 33
OC - Oceania 1
Totale 4.192
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.737
SG - Singapore 609
CN - Cina 329
IT - Italia 318
BD - Bangladesh 184
BR - Brasile 173
IN - India 117
VN - Vietnam 109
DE - Germania 68
HK - Hong Kong 52
GB - Regno Unito 47
NL - Olanda 47
SE - Svezia 44
CA - Canada 36
FI - Finlandia 36
MX - Messico 24
IQ - Iraq 18
ZA - Sudafrica 14
FR - Francia 13
AR - Argentina 12
AT - Austria 9
PK - Pakistan 9
PL - Polonia 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
JP - Giappone 7
TR - Turchia 7
ES - Italia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
RU - Federazione Russa 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PH - Filippine 4
PY - Paraguay 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BH - Bahrain 3
DZ - Algeria 3
ET - Etiopia 3
LT - Lituania 3
TN - Tunisia 3
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
IE - Irlanda 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MN - Mongolia 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 4.192
Salva come PNG Salva come JPEG
Città #
San Jose 440
Singapore 257
Ashburn 234
Santa Clara 121
Chandler 108
Bengaluru 96
Hefei 94
Dallas 91
Beijing 63
Milan 62
Hong Kong 51
Munich 44
New York 40
Chicago 37
Ho Chi Minh City 37
Lawrence 37
Princeton 37
Los Angeles 36
London 27
Rome 26
Helsinki 22
Hanoi 21
São Paulo 21
Wilmington 21
Amsterdam 17
Catanzaro 17
Turku 14
Buffalo 13
Mexico City 13
Naples 13
Brooklyn 11
Assago 10
Atlanta 10
Boardman 10
Chennai 10
Ottawa 10
Haiphong 9
Johannesburg 9
San Francisco 9
Shanghai 9
Baghdad 8
Des Moines 8
Orem 8
Stockholm 8
Brescia 7
Bari 6
Bologna 6
Montreal 6
Redmond 6
Tashkent 6
Warsaw 6
Charlotte 5
Hanover 5
Manchester 5
Nuremberg 5
Palermo 5
Tokyo 5
Augusta 4
Brasília 4
Cape Town 4
Council Bluffs 4
Da Nang 4
Denver 4
Erbil 4
Huntington 4
Jakarta 4
Macaé 4
Madison 4
Nairobi 4
Olomouc 4
Orangeburg 4
Rio de Janeiro 4
Seattle 4
Sorocaba 4
Toronto 4
Verona 4
Addis Ababa 3
Amman 3
Ankara 3
Baku 3
Biên Hòa 3
Boston 3
Campinas 3
Chieti 3
Cosenza 3
Ferrara 3
Guangzhou 3
Houston 3
Jeddah 3
Jersey City 3
Kuala Lumpur 3
Lahore 3
Las Vegas 3
Montevideo 3
Ninh Bình 3
Perugia 3
Porto Alegre 3
Portofino 3
Quito 3
Redwood City 3
Totale 2.460
Salva come PNG Salva come JPEG
Nome #
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 134
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 93
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 88
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 84
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 73
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 70
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 65
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 64
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 64
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 63
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 62
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 60
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 59
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 59
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 58
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 57
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 56
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 55
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 53
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 53
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 53
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 52
Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale. A Systematic review and meta-analysis. 52
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 52
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 50
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 50
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 50
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 50
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 50
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 49
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 47
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 47
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 46
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 46
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 46
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 46
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 46
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 46
Direct Oral Anticoagulants in Patients With Active Cancer 45
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 45
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 44
Non-invasive myocardial work is reduced during transient acute coronary occlusion 44
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 44
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 43
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 42
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 42
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 39
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 39
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 39
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 39
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 38
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 38
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 38
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 36
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 36
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 36
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 35
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 35
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 35
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 35
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 35
Exosomal microRNAs in heart disease 35
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 35
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 34
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 33
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 32
The link between anemia and adverse outcomes in patients with acute coronary syndrome 31
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 31
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 31
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 31
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 31
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 31
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 31
Cerebral Embolic Protection During TAVR 30
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 30
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 30
Stent Thrombosis After Percutaneous Coronary Intervention 29
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 29
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 28
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 28
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 28
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 28
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 27
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 27
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 27
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 26
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 26
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 25
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 23
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 23
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 23
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 23
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 22
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 22
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 20
Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 20
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions 20
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact 20
Paravalvular Leak 19
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 18
Totale 4.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022121 0 0 3 29 11 4 0 28 12 13 18 3
2022/2023370 80 12 40 13 48 29 3 27 57 21 31 9
2023/2024236 29 23 12 12 3 43 0 13 64 5 18 14
2024/2025848 102 35 35 23 60 138 43 16 82 17 117 180
2025/20262.701 100 243 162 288 300 108 316 136 337 221 318 172
Totale 4.389